KNUDSEN, STEEN,JENSEN, PETER BUHL,BUHL, ULLA HALD,RASMUSSEN, ANNIE,MADSEN, MOGENS WINKEL
申请号：
CA3031892
公开号：
CA3031892A1
申请日:
2019.01.30
申请国别(地区):
CA
年份:
2019
代理人:
摘要：
Featured are methods of treating a patient with cancer by administering, e.g.,a secretoryphospholipase A2 (sPLA 2) hydrolysable, cisplatin-containing liposomecomposition (e.g., LiPlaCis).The patient may be assessed for their responsiveness to the liposomal therapyprior to treatmentusing the methods, devices, and kits also described herein for detecting alevel of one or morebiomarkers in a sample from the patient with cancer.
